Sumer Anderson
Psychiatric/Mental Health · Sandy, UTNPI 1992071559
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 424 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 424 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$686
- Neurocrine Biosciences, Inc.$631
- Supernus Pharmaceuticals, Inc.$451
- Teva Pharmaceuticals USA, Inc.$449
- plus $3K from 21 others
What the payments were for
- Food & beverage$8,14999%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,690 |
| Johnson & Johnson(2 entities) | 56 | $1,003 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $686 |
| Neurocrine Biosciences, Inc. | 25 | $631 |
| Supernus Pharmaceuticals, Inc. | 13 | $451 |
| Teva Pharmaceuticals USA, Inc. | 39 | $449 |
| Alkermes, Inc. | 19 | $436 |
| Otsuka America Pharmaceutical, Inc. | 22 | $415 |
| Lundbeck LLC | 18 | $345 |
| Vanda Pharmaceuticals Inc. | 12 | $313 |
| Tris Pharma Inc | 15 | $301 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $224 |
| Corium, LLC | 14 | $212 |
| Sunovion Pharmaceuticals Inc. | 12 | $168 |
| Axsome Therapeutics, Inc. | 8 | $149 |
| Biogen | 6 | $108 |
| Ironshore Pharmaceuticals Inc. | 6 | $107 |
| Indivior Inc. | 6 | $106 |
| Idorsia Pharmaceuticals US Inc | 5 | $86 |
| E.r. Squibb & Sons, L.L.C. | 5 | $79 |
| Braeburn Inc. | 4 | $70 |
| Lilly USA, LLC | 3 | $50 |
| Noven Therapeutics, LLC | 3 | $49 |
| Tempus AI, Inc | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Eisai Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,196 in reported general payments places this provider in the 95th percentile of 393 psychiatric/mental health providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 24 | $37,866 |
| SpravatoEsketamine Hcl | 25 | $31,497 |
| AuvelityDextromethorphan Hbr/Bupropion | 11 | $6,217 |
| BelsomraSuvorexant | 13 | $5,433 |
| Olanzapine OdtOlanzapine | 41 | $2,357 |
| Vilazodone Hcl | 16 | $1,985 |
| Buprenorphine Hcl | 25 | $1,738 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $1,614 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 34 | $1,339 |
| Lurasidone Hcl | 25 | $808 |
| Gabapentin | 24 | $701 |
| Eszopiclone | 20 | $373 |
| Quetiapine Fumarate | 27 | $339 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $297 |
| Lamotrigine | 23 | $206 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,690 | $37,86624 claims |
| Johnson & JohnsonSpravato | $1,003 | $31,49725 claims |
| Axsome Therapeutics, Inc.Auvelity | $149 | $6,21711 claims |
| Lilly USA, LLCOlanzapine | $50 | $19216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 393 psychiatric/mental health providers in Utah.
Other psychiatric/mental health in Sandy
- Jennifer OlsenSandy$6K
- Kim McKinnonSandy$6K
- Landon MoyersSandy$6K
- Kylee PulsipherSandy$5K
- Bret HafenLayton$381K
- Alberto SouzaSaint George$114K
- Anthony BrowningOrem$32K
- Debra HainRiverton$29K
- Kristin BarberSalt Lake City$28K
- Briana TerrySalt Lake City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.